Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

被引:30
作者
Joshi, Maansi [1 ]
Cook, Joselle [1 ]
McCullough, Kristen [1 ]
Nanaa, Ahmad [1 ]
Gangat, Naseema [1 ]
Foran, James M. [2 ]
Murthy, Hemant S. [2 ]
Kharfan-Dabaja, Mohamed A. [2 ]
Sproat, Lisa [3 ]
Palmer, Jeanne [3 ]
Pardanani, Animesh [1 ]
Tefferi, Ayalew [1 ]
Begna, Kebede [1 ]
Elliot, Michelle [1 ]
Al-Kali, Aref [1 ]
Patnaik, Mrinal [1 ]
Shah, Mithun V. [1 ]
Hogan, William J. [1 ]
Litzow, Mark R. [1 ]
Alkhateeb, Hassan B. [1 ]
机构
[1] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Med, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
[3] Mayo Clin, Dept Internal Med, Div Hematol, Scottsdale, AZ USA
关键词
D O I
10.1038/s41408-021-00437-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 15 条
[1]   Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments [J].
Agarwal, Suresh K. ;
DiNardo, Courtney D. ;
Potluri, Jalaja ;
Dunbar, Martin ;
Kantarjian, Hagop M. ;
Humerickhouse, Rod A. ;
Wong, Shekman L. ;
Menon, Rajeev M. ;
Konopleva, Marina Y. ;
Salem, Ahmed Hamed .
CLINICAL THERAPEUTICS, 2017, 39 (02) :359-367
[2]   Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia [J].
Aldoss, Ibrahim ;
Zhang, Jianying ;
Pillai, Raju ;
Shouse, Geoffrey ;
Sanchez, James F. ;
Mei, Matthew ;
Nakamura, Ryotaro ;
Stein, Anthony S. ;
Forman, Stephen J. ;
Marcucci, Guido ;
Pullarkat, Vinod .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) :E45-E48
[3]   Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia [J].
Aldoss, Ibrahim ;
Yang, Dongyun ;
Pillai, Raju ;
Sanchez, James F. ;
Mei, Matthew ;
Aribi, Ahmed ;
Ali, Haris ;
Sandhu, Karamjeet ;
Al Malki, Monzr M. ;
Salhotra, Amandeep ;
Khaled, Samer ;
Sun, Weili ;
O'Donnell, Margaret ;
Snyder, David ;
Nakamura, Ryotaro ;
Stein, Anthony S. ;
Forman, Stephen J. ;
Marcucci, Guido ;
Pullarkat, Vinod .
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) :E253-E255
[4]   Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia [J].
Aldoss, Ibrahim ;
Yang, Dongyun ;
Aribi, Ahmed ;
Ali, Haris ;
Sandhu, Karamjeet ;
Al Malki, Monzr M. ;
Mei, Matthew ;
Salhotra, Amandeep ;
Khaled, Samer ;
Nakamura, Ryotaro ;
Snyder, David ;
O'Donnell, Margaret ;
Stein, Anthony S. ;
Forman, Stephen J. ;
Marcucci, Guido ;
Pullarkat, Vinod .
HAEMATOLOGICA, 2018, 103 (09) :E404-E407
[5]   Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study [J].
Bejanyan, Nelli ;
Weisdorf, Daniel J. ;
Logan, Brent R. ;
Wang, Hai-Lin ;
Devine, Steven M. ;
de Lima, Marcos ;
Bunjes, Donald W. ;
Zhang, Mei-Jie .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) :454-459
[6]  
DiNardo C, 2020, EHA HAEMATOL
[7]   Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].
DiNardo, Courtney D. ;
Pratz, Keith ;
Pullarkat, Vinod ;
Jonas, Brian A. ;
Arellano, Martha ;
Becker, Pamela S. ;
Frankfurt, Olga ;
Konopleva, Marina ;
Wei, Andrew H. ;
Kantarjian, Hagop M. ;
Xu, Tu ;
Hong, Wan-Jen ;
Chyla, Brenda ;
Potluri, Jalaja ;
Pollyea, Daniel A. ;
Letai, Anthony .
BLOOD, 2019, 133 (01) :7-17
[8]   Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies [J].
DiNardo, Courtney D. ;
Rausch, Caitlin R. ;
Benton, Christopher ;
Kadia, Tapan ;
Jain, Nitin ;
Pemmaraju, Naveen ;
Daver, Naval ;
Covert, Wendy ;
Marx, Kayleigh R. ;
Mace, Morgan ;
Jabbour, Elias ;
Cortes, Jorge ;
Garcia-Manero, Guillermo ;
Ravandi, Farhad ;
Bhalla, Kapil N. ;
Kantarjian, Hagop ;
Konopleva, Marina .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (03) :401-407
[9]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[10]   International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts [J].
Dombret, Herve ;
Seymour, John F. ;
Butrym, Aleksandra ;
Wierzbowska, Agnieszka ;
Selleslag, Dominik ;
Jang, Jun Ho ;
Kumar, Rajat ;
Cavenagh, James ;
Schuh, Andre C. ;
Candoni, Anna ;
Recher, Christian ;
Sandhu, Irwindeep ;
Bernal del Castillo, Teresa ;
Al-Ali, Haifa Kathrin ;
Martinelli, Giovanni ;
Falantes, Jose ;
Noppeney, Richard ;
Stone, Richard M. ;
Minden, Mark D. ;
McIntyre, Heidi ;
Songer, Steve ;
Lucy, Lela M. ;
Beach, C. L. ;
Doehner, Hartmut .
BLOOD, 2015, 126 (03) :291-299